Dipivefrin or dipivefrine
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391715This classification denotes an anti-glaucoma agent with the molecular formula C19H29NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8Q1PVL543G, chemically known as 4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat but generally known as dipivefrin, which bears US NIH Compound Identifier 3105. European Medicines Agency schedules Dipivefrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07217MIG. The term DIPIVEFRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules dipivefrin in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, DIPIVEFRIN remains the US FDA Preferred Term for this commodity. Dipivefrin bears US NLM identifiers UMLS ID C0058415 and NCI Concept Code C61729. SMILES: CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.